Table 1.
Secretory pathway | In vitro | In vivo | Type of tau | Secreted tau | References | |
---|---|---|---|---|---|---|
Unconventional protein secretion type I/Translocation through the plasma membrane | Cell lines (Neuro2A, SH-SY5Y, CHO, and HEK293), mouse and rat primary neurons | Wt human tau (0N4R, 2N4R) and E14, endogenous murine tau | Full-length and truncated forms, phosphorylated, mostly small soluble oligomers | Chai et al. (2012), Katsinelos et al. (2018), and Merezhko et al. (2018) | ||
Membranous organelles-based secretion | Exosomal secretion | Cell lines (HEK293, COS7, N2A, and M1C), rat primary neurons | Mouse brain, human CSF | Wt human tau (3R, 0N4R, 1N4R), P301S, 4R domain of human tau ΔK280, endogenous rat tau, and endogenous human tau | Full-length and truncated forms, hypophosphorylated, monomeric and oligomeric, partly insoluble | Saman et al. (2012), Simón et al. (2012), Asai et al. (2015), and Wang et al. (2017) |
Autophagy-based secretion | Cell lines (SH-SY5Y and HEK293), murine primary neurons, human iPSC-derived neurons | Wt human tau (all 6 isoforms), endogenous rat tau, endogenous human tau | Full-length and truncated forms | Tang et al. (2015), Lonati et al. (2018), Kang et al. (2019), and Chen et al. (2020) | ||
LE/lysosomal secretion | Cell lines (HEK293, M17, and HeLa), rat primary neurons, mouse organotypic brain slices | Wt tau (0N4R and 1N4R), R406W, P301L, and endogenous murine tau | Truncated forms, hypophosphorylated | Fontaine et al. (2016), Rodriguez et al. (2017), and Xu Y. et al. (2018) | ||
Ectosomal secretion | Cell line (N1-E115), rat primary neurons | Rat ISF, human CSF | Wt human tau (1N4R), endogenous rat tau, endogenous human tau | Full-length, C- and N-terminal truncated forms | Dujardin et al. (2014) and Spitzer et al. (2019) |
E14, a pseudo hyperphosphorylated form of tau; wt, wild type; CSF, cerebrospinal fluid; iPSC, induced pluripotent stem cell; ISF, interstitial fluid.